Beurs gesloten -
Japan Exchange
08:00:00 05-07-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.340
JPY
|
-1,18%
|
|
-0,30%
|
+4,77%
|
Fiscaal tijdperk: oktober |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
15.629
|
51.949
|
119.696
|
82.122
|
35.225
|
26.539
|
-
|
-
|
Bedrijfswaarde
1 |
15.629
|
50.196
|
117.288
|
78.999
|
30.541
|
26.539
|
26.539
|
26.539
|
K/w-verhouding
|
59,1
x
|
187
x
|
183
x
|
80,6
x
|
36,5
x
|
47,2
x
|
39,2
x
|
29,4
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
1,12%
|
0,3%
|
0,35%
|
0,42%
|
Marktkapitalisatie/omzet
|
9,7
x
|
28
x
|
41
x
|
19,2
x
|
7,81
x
|
5,71
x
|
5,17
x
|
4,55
x
|
Bedrijfswaarde/omzet
|
9,7
x
|
28
x
|
41
x
|
19,2
x
|
7,81
x
|
5,71
x
|
5,17
x
|
4,55
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
50,3
x
|
27,4
x
|
32,7
x
|
24,6
x
|
18,7
x
|
Bedrijfswaarde/FCF
|
107
x
|
177
x
|
-
|
121
x
|
120
x
|
103
x
|
43,6
x
|
31,9
x
|
FCF Yield
|
0,93%
|
0,56%
|
-
|
0,83%
|
0,83%
|
0,97%
|
2,29%
|
3,14%
|
Price to Book
|
9,72
x
|
25,6
x
|
44,4
x
|
22
x
|
5,73
x
|
4,28
x
|
3,92
x
|
3,51
x
|
Aantal aandelen (in duizenden)
|
17.280
|
18.335
|
18.586
|
18.685
|
19.756
|
19.806
|
-
|
-
|
Referentieprijs
2 |
904,4
|
2.833
|
6.440
|
4.395
|
1.783
|
1.340
|
1.340
|
1.340
|
Datum van publicatie
|
12/12/19
|
14/12/20
|
13/12/21
|
14/12/22
|
15/12/23
|
-
|
-
|
-
|
Fiscaal tijdperk: oktober |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.611
|
1.855
|
2.922
|
4.274
|
4.510
|
4.646
|
5.133
|
5.829
|
EBITDA
1 |
-
|
-
|
-
|
1.631
|
1.285
|
810,7
|
1.080
|
1.416
|
Bedrijfsresultaat (EBIT)
1 |
326
|
415
|
992
|
1.571
|
1.221
|
706
|
955,3
|
1.292
|
Operationele Marge
|
20,24%
|
22,37%
|
33,95%
|
36,76%
|
27,07%
|
15,2%
|
18,61%
|
22,16%
|
Resultaat voor belastingen (EBT)
1 |
303
|
412
|
1.006
|
1.584
|
1.239
|
792
|
955
|
1.292
|
Nettowinst (verlies)
1 |
199
|
274
|
651
|
1.018
|
923
|
561,7
|
675,7
|
901,7
|
Nettomarge
|
12,35%
|
14,77%
|
22,28%
|
23,82%
|
20,47%
|
12,09%
|
13,16%
|
15,47%
|
WPA
2 |
15,30
|
15,19
|
35,17
|
54,54
|
48,88
|
28,40
|
34,17
|
45,57
|
Free Cash Flow
1 |
146
|
293
|
-
|
678,2
|
293
|
257
|
609
|
833
|
FCF-marge
|
9,06%
|
15,8%
|
-
|
15,87%
|
6,5%
|
5,53%
|
11,87%
|
14,29%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
41,57%
|
22,8%
|
31,7%
|
56,37%
|
58,84%
|
Kasstroomconversie (nettowinst)
|
73,37%
|
106,93%
|
-
|
66,63%
|
31,74%
|
45,76%
|
90,13%
|
92,38%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
20,00
|
4,000
|
4,667
|
5,667
|
Datum van publicatie
|
12/12/19
|
14/12/20
|
13/12/21
|
14/12/22
|
15/12/23
|
-
|
-
|
-
|
Fiscaal tijdperk: oktober |
2020 S1
|
2021 S1
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Omzet
1 |
886
|
1.343
|
820
|
1.697
|
1.175
|
1.401
|
2.577
|
1.060
|
1.111
|
2.171
|
1.236
|
1.174
|
1.054
|
2.228
|
1.130
|
1.203
|
2.508
|
1.139
|
1.172
|
1.208
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
187
|
422
|
244
|
490
|
448
|
633,1
|
1.081
|
351,3
|
308,1
|
659,3
|
384
|
205,9
|
75,61
|
281,5
|
284
|
105,5
|
593
|
149
|
183
|
198
|
Operationele Marge
|
21,11%
|
31,42%
|
29,76%
|
28,87%
|
38,13%
|
45,19%
|
41,95%
|
33,15%
|
27,73%
|
30,38%
|
31,07%
|
17,54%
|
7,17%
|
12,64%
|
25,12%
|
8,77%
|
23,64%
|
13,08%
|
15,61%
|
16,39%
|
Resultaat voor belastingen (EBT)
1 |
187
|
435
|
244
|
495
|
451
|
637,6
|
1.089
|
339,6
|
319,3
|
658,8
|
426
|
212,7
|
227,1
|
439,8
|
332
|
-146
|
-
|
149
|
183
|
198
|
Nettowinst (verlies)
1 |
118
|
268
|
155
|
308
|
281
|
428,8
|
709,8
|
216
|
194
|
410,1
|
265
|
143,9
|
156,1
|
300
|
193,5
|
59,5
|
371
|
103
|
127
|
138
|
Nettomarge
|
13,32%
|
19,96%
|
18,9%
|
18,15%
|
23,91%
|
30,61%
|
27,55%
|
20,39%
|
17,46%
|
18,89%
|
21,44%
|
12,26%
|
14,81%
|
13,47%
|
17,12%
|
4,95%
|
14,79%
|
9,04%
|
10,84%
|
11,42%
|
WPA
|
6,641
|
14,55
|
8,360
|
16,54
|
15,04
|
-
|
-
|
11,56
|
10,38
|
21,94
|
14,05
|
7,270
|
-
|
15,15
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
15/06/20
|
14/06/21
|
16/03/22
|
13/06/22
|
13/09/22
|
14/12/22
|
14/12/22
|
14/03/23
|
14/06/23
|
14/06/23
|
13/09/23
|
11/03/24
|
13/06/24
|
13/06/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: oktober |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
1.753
|
2.408
|
3.123
|
4.684
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
146
|
293
|
-
|
678
|
293
|
257
|
609
|
833
|
ROE (netto-inkomsten/eigen vermogen)
|
19,9%
|
15%
|
27,5%
|
31,6%
|
18,7%
|
9,13%
|
10,5%
|
12,7%
|
ROA (netto-inkomsten/totale activa)
|
23,9%
|
19,6%
|
35,2%
|
25,6%
|
20,8%
|
10,4%
|
12,6%
|
14,7%
|
Totale activa
1 |
833,8
|
1.395
|
1.850
|
3.983
|
4.436
|
5.401
|
5.362
|
6.155
|
Nettoactief per aandeel
2 |
93,00
|
111,0
|
145,0
|
200,0
|
311,0
|
313,0
|
342,0
|
381,0
|
Cashflow per aandeel
2 |
20,20
|
18,80
|
38,10
|
57,80
|
53,20
|
36,00
|
45,00
|
51,00
|
Capex
1 |
49
|
37
|
55
|
99,2
|
553
|
250
|
90
|
76,7
|
Capex/omzet
|
3,04%
|
1,99%
|
1,88%
|
2,32%
|
12,26%
|
5,38%
|
1,75%
|
1,32%
|
Datum van publicatie
|
12/12/19
|
14/12/20
|
13/12/21
|
14/12/22
|
15/12/23
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +4,77% | 165 mln. | | -18,64% | 8,46 mld. | | +71,50% | 4,41 mld. | | +11,92% | 2,88 mld. | | -2,80% | 2,64 mld. | | -16,07% | 1,73 mld. | | -57,49% | 1,7 mld. | | -16,46% | 1,5 mld. | | -49,06% | 1,03 mld. | | +16,62% | 968 mln. |
Medische en diagnostische laboratoria
|